NO831100L - Substituerte 3,4-diamino-1,2,5-tiadiazoler med histamin h2-reseptorantagonistvirkning - Google Patents

Substituerte 3,4-diamino-1,2,5-tiadiazoler med histamin h2-reseptorantagonistvirkning

Info

Publication number
NO831100L
NO831100L NO831100A NO831100A NO831100L NO 831100 L NO831100 L NO 831100L NO 831100 A NO831100 A NO 831100A NO 831100 A NO831100 A NO 831100A NO 831100 L NO831100 L NO 831100L
Authority
NO
Norway
Prior art keywords
thiadiazoles
histamine
diamino
substituted
receptor antagonist
Prior art date
Application number
NO831100A
Other languages
English (en)
Other versions
NO163055B (no
NO163055C (no
Inventor
Ronnie Ray Crenshaw
Aldo Antonio Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO831100L publication Critical patent/NO831100L/no
Priority to NO873186A priority Critical patent/NO166531C/no
Priority to NO880872A priority patent/NO880872D0/no
Publication of NO163055B publication Critical patent/NO163055B/no
Publication of NO163055C publication Critical patent/NO163055C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO831100A 1982-03-29 1983-03-28 Fremgangsmaate til fremstilling av substituerte 3,4-diamino-1,2,5-tiadiazoler. NO163055C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO873186A NO166531C (no) 1982-03-29 1987-07-30 Fremgangsmaate til fremstilling av substituerte etandiimidamider.
NO880872A NO880872D0 (no) 1982-03-29 1988-02-29 Fremgangsmaate til fremstilling av en kjemisk forbindelse.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (3)

Publication Number Publication Date
NO831100L true NO831100L (no) 1983-09-30
NO163055B NO163055B (no) 1989-12-18
NO163055C NO163055C (no) 1990-03-28

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831100A NO163055C (no) 1982-03-29 1983-03-28 Fremgangsmaate til fremstilling av substituerte 3,4-diamino-1,2,5-tiadiazoler.

Country Status (30)

Country Link
JP (2) JPS58180477A (no)
KR (1) KR880002209B1 (no)
AT (1) AT386599B (no)
AU (2) AU557577B2 (no)
BE (1) BE896291A (no)
CH (2) CH655111A5 (no)
CS (2) CS250229B2 (no)
DD (2) DD210909A5 (no)
DE (1) DE3311281A1 (no)
DK (2) DK166677B1 (no)
ES (3) ES520982A0 (no)
FR (2) FR2542741B1 (no)
GB (2) GB2117769B (no)
GR (1) GR78524B (no)
HU (2) HU188742B (no)
IE (1) IE55596B1 (no)
IL (1) IL68259A0 (no)
IT (1) IT1164633B (no)
LU (1) LU84716A1 (no)
MY (1) MY8700942A (no)
NL (1) NL8301063A (no)
NO (1) NO163055C (no)
NZ (1) NZ203726A (no)
OA (1) OA07356A (no)
PT (1) PT76459B (no)
SE (2) SE461040B (no)
SU (2) SU1419518A3 (no)
YU (1) YU44849B (no)
ZA (1) ZA832154B (no)
ZW (1) ZW7683A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
FI76795C (fi) * 1979-09-04 1988-12-12 Bristol Myers Co Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter.
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
JPH0568472B2 (no) 1993-09-29
YU44849B (en) 1991-04-30
AT386599B (de) 1988-09-12
NZ203726A (en) 1986-05-09
ES8404683A1 (es) 1984-05-16
ES8505977A1 (es) 1985-06-16
CH660880A5 (de) 1987-05-29
IL68259A0 (en) 1983-06-15
DE3311281A1 (de) 1983-11-24
DK141383A (da) 1983-09-30
SU1419518A3 (ru) 1988-08-23
AU557577B2 (en) 1986-12-24
JPH06135925A (ja) 1994-05-17
BE896291A (fr) 1983-09-28
CH655111A5 (de) 1986-03-27
GB2117769A (en) 1983-10-19
AU6327286A (en) 1987-01-08
GB2149406A (en) 1985-06-12
GB8432809D0 (en) 1985-02-06
SE461040B (sv) 1989-12-18
GB8308518D0 (en) 1983-05-05
FR2597867B1 (fr) 1989-12-08
AU586037B2 (en) 1989-06-29
PT76459B (en) 1986-03-11
DK81192A (da) 1992-06-18
FR2542741A1 (fr) 1984-09-21
IE55596B1 (en) 1990-11-21
SE8704689L (sv) 1987-11-25
SE8301725D0 (sv) 1983-03-28
MY8700942A (en) 1987-12-31
GR78524B (no) 1984-09-27
YU74483A (en) 1986-02-28
NL8301063A (nl) 1983-10-17
ZW7683A1 (en) 1984-01-04
SU1355123A3 (ru) 1987-11-23
IT8348005A0 (it) 1983-03-28
DK81192D0 (da) 1992-06-18
KR880002209B1 (ko) 1988-10-18
ZA832154B (en) 1983-12-28
ES8505978A1 (es) 1985-06-16
AU1290783A (en) 1983-10-06
SE8301725L (sv) 1983-11-25
NO163055B (no) 1989-12-18
DD219768A5 (de) 1985-03-13
DK141383D0 (da) 1983-03-28
GB2117769B (en) 1985-08-29
HU196386B (en) 1988-11-28
ES527686A0 (es) 1985-06-16
IT1164633B (it) 1987-04-15
ATA111083A (de) 1988-02-15
PT76459A (en) 1983-04-01
IE830686L (en) 1983-09-29
KR840004095A (ko) 1984-10-06
LU84716A1 (fr) 1983-12-05
FR2542741B1 (fr) 1989-12-08
DK166677B1 (da) 1993-06-28
FR2597867A1 (fr) 1987-10-30
JPS58180477A (ja) 1983-10-21
GB2149406B (en) 1986-01-02
DD210909A5 (de) 1984-06-27
ES520982A0 (es) 1984-05-16
CS250229B2 (en) 1987-04-16
SE464302B (sv) 1991-04-08
ES527685A0 (es) 1985-06-16
OA07356A (fr) 1984-08-31
NO163055C (no) 1990-03-28
CS250240B2 (en) 1987-04-16
HU188742B (en) 1986-05-28
SE8704689D0 (sv) 1987-11-25

Similar Documents

Publication Publication Date Title
DK435681A (da) Pyrimidonderivater med histamin h2-antagonistvirkning
FI922143A7 (fi) Muscarinreceptorantagonister.
FI922344L (fi) Muscarinreceptorantagonister.
DE3574665D1 (de) Glutamatrezeptorshemmstoff.
ZA801002B (en) Histamine antagonists
ES530590A0 (es) Un procedimiento para la preparacion de antagonistas de los receptores h-2 de la histamina.
DK298180A (da) Histamin h2-antagonister
NO831100L (no) Substituerte 3,4-diamino-1,2,5-tiadiazoler med histamin h2-reseptorantagonistvirkning
FI902763A7 (fi) Heterosyklinen yhdiste, jolla on antagonistinen aktiviteetti serotoniinin 2-reseptoriin
FI894675A7 (fi) Muskarinreceptorantagonister.
ZA783141B (en) Histamine h2 receptor antagonists
FI845095A7 (fi) Aminoimidatsolonijohdannaiset histamiini-H2-antagonisteina.
NO791764L (no) Fremgangsmaate for fremstilling av nitroforbindelser med histamin h2-reseptor antagonistvirkning
ZA894097B (en) Alpha-adrenergic receptor antagonists
NO843726L (no) 2,5-disubstituerte-4(3h)-pyrimidoner med histamin h2-reseptor antagonistvirkning
NO852519L (no) Substituerte 3,4-diamino-1,2,5-tiadiazoler med hestamin h2-reseptor antagonistisk virkning
NL7805935A (nl) N-cyano-n'-(2-/(4-methyl-5-imidazolyl)methylthio ethyl)-n''-alkynylguanidinen met h2-receptor blokkeren- de werking.
DK331877A (da) Histamin h2-antagonister
DK325784A (da) Cytosinderivater, som er histamin h2-antagonister
FI922346A7 (fi) Muscarinreceptorantagonister.
DE69004827D1 (de) Alpha-adrenergene Rezeptor-Antagonisten.
FI905922A7 (fi) a-adrenergisen reseptorin antagonistit
DK624284A (da) Aminoimidazolinonderivater som histamin h2-antagonister
DK531483D0 (da) Fremgangsmade til fremstilling af histamin h2-antagonister
IE881220L (en) 5-ht3 receptor antagonists